PE20030763A1 - Inhibidores de la integrasa del vih - Google Patents

Inhibidores de la integrasa del vih

Info

Publication number
PE20030763A1
PE20030763A1 PE2002001198A PE2002001198A PE20030763A1 PE 20030763 A1 PE20030763 A1 PE 20030763A1 PE 2002001198 A PE2002001198 A PE 2002001198A PE 2002001198 A PE2002001198 A PE 2002001198A PE 20030763 A1 PE20030763 A1 PE 20030763A1
Authority
PE
Peru
Prior art keywords
alkyl
aryl
metoxy
carbamoyl
cycloalkyl
Prior art date
Application number
PE2002001198A
Other languages
English (en)
Inventor
Michael A Walker
Jacques Banville
Serge Plamondon
Roger Remillard
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20030763A1 publication Critical patent/PE20030763A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C207/00—Compounds containing nitroso groups bound to a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C207/00—Compounds containing nitroso groups bound to a carbon skeleton
    • C07C207/04—Compounds containing nitroso groups bound to a carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C255/64—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA I DONDE R1 ES ARILO, ALQUILO C1-C6-ARILO, ALQUILO C1-C6-S(O)n-ARILO, ALQUILO C1-C5-O-ARILO Y DONDE R1 ESTA SIN SUSTITUIR O SUSTITUIDO SON H, HALO, CN, ALQUILO C1-C6, CICLOALQUILO C3-C6, OR4, ALQUILO C1-C10-O-R4, CO2R5, ENTRE OTROS; R2 ES H, ALQUILO C1-C10, CICLOALQUILO C3-C6, HALOALQUILO C1-C10, ARILO, HETEROARILO, ENTRE OTROS; R4-R6 SON H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ENTRE OTROS; B1 ES EN GRUPO a, b, ENTRE OTROS. SON COMPUESTOS PREFERIDOS ACIDO 3-[(4-FLUORO-BENCIL)-METOXI-CARBAMOIL]-2-HIDROXI-ACRILICO, ACIDO 3-[(3,4-DIFLUORO-BENCIL)-METOXI-CARBAMOIL]-2-HIDROXI-ACRILICO, ACIDO 3-[(3-BROMO-4-FLUORO-BENCIL)-METOXI-CARBAMOIL]-2-HIDROXI-ACRILICO, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LA INTEGRASA DEL VIH Y SON UTILES PARA EL TRATAMIENTO DEL VIH
PE2002001198A 2001-12-12 2002-12-12 Inhibidores de la integrasa del vih PE20030763A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33967401P 2001-12-12 2001-12-12

Publications (1)

Publication Number Publication Date
PE20030763A1 true PE20030763A1 (es) 2003-09-13

Family

ID=23330105

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001198A PE20030763A1 (es) 2001-12-12 2002-12-12 Inhibidores de la integrasa del vih

Country Status (24)

Country Link
US (1) US6777440B2 (es)
EP (1) EP1467695A2 (es)
JP (1) JP2005515206A (es)
KR (1) KR20040065251A (es)
CN (1) CN1617849A (es)
AR (1) AR037770A1 (es)
AU (1) AU2002366604A1 (es)
BR (1) BR0214842A (es)
CA (1) CA2469592C (es)
CO (1) CO5590909A2 (es)
HR (1) HRP20040534A2 (es)
HU (1) HUP0402675A2 (es)
IL (1) IL162325A0 (es)
IS (1) IS7305A (es)
MX (1) MXPA04005623A (es)
NO (1) NO20042916L (es)
NZ (1) NZ533413A (es)
PE (1) PE20030763A1 (es)
PL (1) PL370664A1 (es)
RU (1) RU2284315C2 (es)
TW (1) TWI252757B (es)
UY (1) UY27577A1 (es)
WO (1) WO2003049690A2 (es)
ZA (1) ZA200404628B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BRPI0407052A (pt) 2003-01-27 2006-01-17 Pfizer Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização
US6890942B2 (en) * 2003-05-16 2005-05-10 Bristol-Myers Squibb Company Acyl sulfonamides as inhibitors of HIV integrase
US20050215544A1 (en) * 2004-03-24 2005-09-29 Pin-Fang Lin Methods of treating HIV infection
US7776863B2 (en) * 2004-03-24 2010-08-17 Bristol-Myers Squibb Company Methods of treating HIV infection
EP1756103A2 (en) 2004-04-26 2007-02-28 Pfizer, Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
CA2563761C (en) 2004-04-26 2009-12-29 Pfizer Inc. Inhibitors of the hiv integrase enzyme
US7507838B2 (en) * 2004-09-01 2009-03-24 Bristol-Myers Squibb Company Process for the preparation of Z-5-carboxymethylene-1,3-dioxolan-4-ones
US20060058286A1 (en) * 2004-09-16 2006-03-16 Mark Krystal Methods of treating HIV infection
WO2007086584A1 (ja) * 2006-01-30 2007-08-02 Meiji Seika Kaisha, Ltd. 新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤
WO2008004100A2 (en) 2006-07-05 2008-01-10 Pfizer Products Inc. Therapeutic compounds
CA2744509C (en) * 2008-12-05 2013-10-22 Syngenta Participations Ag Novel pyrazole-4-n-alkoxycarboxamides as microbiocides
WO2011076765A1 (en) 2009-12-23 2011-06-30 Katholieke Universiteit Leuven Novel antiviral compounds
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
WO2012065963A2 (en) 2010-11-15 2012-05-24 Katholieke Universiteit Leuven Novel antiviral compounds
EP2640729B1 (en) 2010-11-15 2016-12-21 VIIV Healthcare UK Limited Inhibitors of hiv replication
IN2014DN09934A (es) * 2012-04-26 2015-08-14 Bayer Cropscience Ag

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR029304A1 (es) * 1998-06-26 2003-06-25 Daiichi Seiyaku Co DERIVADOS DE PROPIONILO SUSTITUIDOS, PRODUCTO FARMACEUTICO, USO PARA LA FABRICACION DE UNA COMPOSICION FARMACEUTICA PARA LA PREVENCION Y/O TRATAMIENTO DE HIPERCOLESTEROLEMIA, HIPERLIPEMIA O ARTERIOESCLEROSIS, COMPOSICIoN FARMACÉUTICA Y COMPUESTOS INTERMEDIARIOS

Also Published As

Publication number Publication date
MXPA04005623A (es) 2004-12-06
PL370664A1 (en) 2005-05-30
US6777440B2 (en) 2004-08-17
TWI252757B (en) 2006-04-11
TW200301105A (en) 2003-07-01
KR20040065251A (ko) 2004-07-21
WO2003049690A3 (en) 2004-01-22
HUP0402675A2 (hu) 2005-03-29
CO5590909A2 (es) 2005-12-30
RU2284315C2 (ru) 2006-09-27
IS7305A (is) 2004-06-10
UY27577A1 (es) 2003-07-31
AR037770A1 (es) 2004-12-01
NZ533413A (en) 2006-09-29
CA2469592A1 (en) 2003-06-19
NO20042916L (no) 2004-09-10
RU2004119963A (ru) 2006-01-10
IL162325A0 (en) 2005-11-20
HRP20040534A2 (en) 2005-04-30
WO2003049690A2 (en) 2003-06-19
EP1467695A2 (en) 2004-10-20
CN1617849A (zh) 2005-05-18
BR0214842A (pt) 2005-01-11
CA2469592C (en) 2005-08-23
US20030176495A1 (en) 2003-09-18
AU2002366604A1 (en) 2003-06-23
JP2005515206A (ja) 2005-05-26
ZA200404628B (en) 2005-09-01

Similar Documents

Publication Publication Date Title
PE20030763A1 (es) Inhibidores de la integrasa del vih
DK0540956T3 (da) Fremgangsmåde til fremstilling af substituerede maleinimider
PT655996E (pt) Benzilaminas substituidas contendo heterociclicos nao aromaticos contendo azoto
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
NO307047B1 (no) Nye hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere, farmasøytisk preparat inneholdende slike, og anvendelse derav
AR035777A1 (es) Derivados de pirazol sustituidos, procesos para su preparacion, composiciones farmaceuticas que los contienen, y su uso en medicina
AR019427A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa, procedimiento para su preparacion, su uso para la preparacion de medicamentos, composiciones farmaceuticas y compuestos intermediarios utiles para su preparacion
PE107999A1 (es) Derivados 3-amidinoanilina, inhibidores del factor x de coagulacion de la sangre activado e intermediarios de los mismos
AR039226A2 (es) Compuestos utiles como intermediarios de preparacion y procedimientos
DK0479546T3 (da) Piperazinderivater
PE20040828A1 (es) Benzoxazinonas como modulares de 5-hidroxitriptamina (5-ht)
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
AR041882A1 (es) Compuestos de imidazopiridina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2291722T3 (es) Aminoalcoxiindoles como ligandos 5-ht6-receptores para el tratamiento de transtornos del snc.
PE20060384A1 (es) Derivados de acido benzoico como inhibidores no nucleosidos de la transcriptasa inversa
MXPA04005940A (es) Acidos 3-(imidazolil)-2-aminopropanoicos.
PE20050160A1 (es) 3-aminopirrolidinas como inhibidores de la captacion de monoaminas
HUT38648A (en) Process for producing beta-lactam antibiotica and pharmaceutical, growth-controlling and antioxidative compositions
ES2177816T3 (es) Derivados de azahexano como isosteros de sustrato de aspartato proteasas retroviricas.
ES2096874T3 (es) Inhibidor de la proteasa de hiv util para el tratamiento del sida.
DE69201596T2 (de) 7-Oxabicycloheptyl-substituierte, heterocyclische Amid-Prostaglandin-Analoge, verwendbar bei der Behandlung von vasospastischen und thrombotischen Krankheiten.
PE20030929A1 (es) Acidos 3-(imidazolil)-2-alcoxipropanoicos
CO5540311A2 (es) Derivados de pirimidina utiles como inhibidores de cox-2 selectivos
PE20011003A1 (es) Inhibidores de metaloproteasas
PE20020342A1 (es) Grupos quinuclidina sustituidos con heteroarilo para el tratamiento de enfermedades

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed